Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 1003-1008     DOI: 10.31083/j.rcm2203109
Special Issue: State-of-the-Art Cardiovascular Medicine in Asia 2021
Original Research Previous articles | Next articles
Trends and distribution of coronary heart disease mortality rate in Hexi Corridor, Gansu, China from 2006 to 2015
Xinghui Li1, Zhihe Da2, *(), Xiaolan Ren3, Yan Qiao4, Ping Xie1, Xiaolong Sun1, Lijun Wang1, Junxian Han1, Yongfeng Hua1
1Department of Cardiology, Gansu Provincial People’s Hospital, 730000 Lanzhou, Gansu, China
2Department of Cardiology, Wuwei Hospital of Traditional Chinese Medicine, 733000 Wuwei, Gansu, China
3Department of Chronic Non-infectious Disease Prevention and Control, Gansu Center for Disease Control and Prevention, 730000 Lanzhou, Gansu, China
4Department of Internal Medicine, Chengguan District People’s Hospital, 730030 Lanzhou, Gansu, China
Download:  PDF(600KB)  ( 140 ) Full text   ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract:

This study described the trend and distribution of coronary heart disease (CHD) in the Hexi Corridor region of Gansu. The CHD mortality rates from 2006–2015 were obtained through the Death Reporting System of Gansu Centers for Disease Control (CDC) for 2006–2015. The overall mortality rate of CHD in the Hexi Corridor showed a decreasing trend, increasing in winter and spring and lowest in summer. The CHD mortality rate was higher in men than in women (P < 0.05) and increased with age (P < 0.05). The mortality rate was higher in rural areas than in urban areas (P < 0.05). A ten-year mortality rate trend analysis showed that CHD mortality rate in women has significantly decreased. Specifically, women aged 18–39 years experienced increased There was little change in CHD mortality among women aged 40–59 years, and a declined in CHD mortality among women 60 years and older and women in urban areas. Further analysis showed that in the 18–39-year-old and 40–59-year-old groups and in urban areas, CHD mortality rate was higher in men than in women (P < 0.05). From 2006 to 2015, the mortality rate of CHD in the Hexi Corridor of Gansu was lower than in the national average, but in certain populations such as men, young and middle-aged group and rural areas, the CHD mortality rate was gradually increased. There has been a gradual and progressive decline in CHD mortality rate compared to the rising trend in China. This is due to fewer risk factors in the region, effective drug treatment and improvements in environmental pollution. However, there is still a need to enhance the experience of effective prevention and control for specific subgroups such as men, young people and rural residents, and to take appropriate measures to prevent the occurrence of CHD.

Key words:  Mortality      Coronary heart disease      Hexi Corridor      Trends      Distribution     
Submitted:  10 April 2021      Revised:  27 July 2021      Accepted:  04 August 2021      Published:  24 September 2021     
Fund: 81660065/National Natural Science Foundation of China
*Corresponding Author(s):  Zhihe Da     E-mail:  zhihed2020@126.com

Cite this article: 

Xinghui Li, Zhihe Da, Xiaolan Ren, Yan Qiao, Ping Xie, Xiaolong Sun, Lijun Wang, Junxian Han, Yongfeng Hua. Trends and distribution of coronary heart disease mortality rate in Hexi Corridor, Gansu, China from 2006 to 2015. Reviews in Cardiovascular Medicine, 2021, 22(3): 1003-1008.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203109     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/1003

Fig. 1.  Maps of China and Gansu province, the Hexi Corridor. (A) Location of Gansu Province in China. (B) Location of Hexi Corridor in Gansu Province.

Table 1.  Demographic Characteristics in Hexi Corridor from 2006 to 2015.
CHD cases Number of deaths
(n (%))
Sex
Men 16242 (60.93)
Women 10414 (39.07) a
Age group (years)
18–39 341 (1.28)
40–59 6768 (25.39)
60 19547 (73.33) b
Area group
Urban 11903 (44.65)
Rural 14753 (55.35) c
Compared with men, aP < 0.05; compared with 40–59 years old group, bP < 0.05; Compared with urban group, cP < 0.05.
Table 2.  The distribution of CHD mortality stratified by sex, age and area in Hexi Corridor from 2006 to 2015.
Relative mortality Number of men deaths Number of women deaths
(/10,0000)/Year (n (/10,0000))/Year (n (/10,0000))/Year
Overall 56.42 16242 (34.38) a1 10414 (22.04)
18–39 0.72 317 (0.67) a2 24 (0.05)
40–59 14.33 5872 (12.43) a3 896 (1.90)
60 41.38 b 10053 (21.28) 9494 (20.10)
Urban 25.20 8641 (18.29) a4 3262 (6.91)
Rural 31.23 c 7601(16.09) 7152 (15.14)
Compared with women, a1-4P < 0.05; compared with 18–39 years old and 40–59 years old groups, bP < 0.05; Compared with urban group, cP < 0.05.
Fig. 2.  The trend distribution by time. (A) Trend distribution of CHD mortality rate in Hexi Corridor from 2006 to 2015. (B) Monthly Trend distribution of CHD mortality rate in Hexi Corridor from 2006 to 2015.

Fig. 3.  The subgroup analysis by gender, age and area. (A) The sex distribution of CHD mortality rate in Hexi Corridor from 2006 to 2015. (B) The age distribution of CHD mortality rate in Hexi Corridor from 2006 to 2015. (C) The area distribution of CHD mortality rate in Hexi Corridor from 2006 to 2015.

[1] Statistical Information Center of the State Health and Family Planning Commission, Center for the Prevention and Control of Chronic Non-communicable Diseases, China Center for Disease Control and Prevention. China Death Cause Monitoring Data Set 2014. Beijing: China Science and Technology Press. 2016.
[2] World Health Organization. Cardiovascular Diseases [EB/OL]. 2017. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/ (Accessed: 10 January 2020).
[3] Wang Y, Li Y, Liu X, Zhang H, Abdulai T, Tu R, et al. Prevalence and Influencing Factors of Coronary Heart Disease and Stroke in Chinese Rural Adults: The Henan Rural Cohort Study. Frontiers in Public Health. 2020; 7: 411.
[4] Ritchey MD, Loustalot F, Bowman BA, Hong Y. Trends in Mortality Rates by Subtypes of Heart Disease in the United States, 2000–2010. Journal of the American Medical Association. 2014; 312: 2037.
[5] Berg J, Björck L, Lappas G, O’Flaherty M, Capewell S, Rosengren A. Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovascular Disorders. 2014; 14: 9.
[6] Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009. European Heart Journal. 2013; 34: 3017–3027.
[7] Wang W, Zhao D. Research and application of epidemiological characteristics, influencing factors and prevention strategies of cardiovascular and cerebrovascular diseases in China. Chinese Journal of Cardiovascular Disease. 2013; 992.
[8] Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, (ICD-10). 2010. Available at: http://www.cdc.gov/nchs/icd/icd10.htm (Accessed: 20 December 2019).
[9] IBM. IBM SPSS Statistics. 2021. Available at: https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-20 (Accessed: 11 December 2020).
[10] Hu SS, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, et al. Summary of China Cardiovascular Disease Report 2108. Chinese Journal of Circulation. 2019; 34 :209–220.
[11] Cox LAT, Liu X, Shi L, Zu K, Goodman J. Applying Nonparametric Methods to Analyses of Short-Term Fine Particulate Matter Exposure and Hospital Admissions for Cardiovascular Diseases among Older Adults. International Journal of Environmental Research and Public Health. 2017; 14: 1051.
[12] Xu MM, Jia YP, Li GX, Liu LQ, Mo YZ, Jin XB, et al. Relationship between ambient fine particles and ventricular repolarization changes and heart rate variability of elderly people with heart disease in Beijing, China. Biomedical and Environmental Sciences. 2013; 26: 629–637.
[13] Matsukawa R, Michikawa T, Ueda K, Nitta H, Kawasaki T, Tashiro H, et al. Desert dust is a risk factor for the incidence of acute myocardial infarction in Western Japan. Circulation. Cardiovascular Quality and Outcomes. 2014; 7: 743–748.
[14] Peng H, Zhao X, Bi T, Yuan X, Guo J, Peng S. PM2.5 obtained from urban areas in Beijing induces apoptosis by activating nuclear factor-kappa B. Military Medical Research. 2017; 4: 27.
[15] Yang X, Feng L, Zhang Y, Shi Y, Liang S, Zhao T, et al. Integrative analysis of methylome and transcriptome variation of identified cardiac disease-specific genes in human cardiomyocytes after PM2.5 exposure. Chemosphere. 2018; 212: 915–926.
[16] Wang Y, Liu SQ, Zhou L, Han J, Zhang J. Epidemiological characteristics of circulatory system disease mortality in Jinan residents from 2011 to 2015. Modern Preventive Medicine. 2017; 44: 25.
[17] Wang W, Liu MB, Sui H, Yang JG. Epidemiological status, prevention and treatment of cardiovascular diseases in China. Chinese Journal of Cardiology. 2012; 17: 321–323.
[18] Hanna P, Shivkumar K, Ardell JL. Calming the Nervous Heart: Autonomic Therapies in Heart Failure. Cardiac Failure Review. 2018; 4: 92.
[19] Chen YS, Zhang YM, Kong ZX, Yu JJ, Sun TT, Zhang HY. Survey on prevalence of overweight and obesity among children and adolescents in China. Chinese Journal of Disease Control. 2017; 21: 866–869.
[20] Xu LL, Ye RF, Zhou JH, Zhou JH, Geng QS. Analysis of coronary lesion characteristics and risk factors in patients with coronary heart disease of different gender. Chinese Journal of Gerontology. 2012; 32: 905–907.
[21] Puymirat E, Simon T, Steg PG, Schiele F, Guéret P, Blanchard D, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. Journal of the American Medical Association. 2012; 308: 998–1006.
[22] Chen B, Zhang JL, Shen ZF. Follow-up analysis of 276 patients with cardiovascular and cerebrovascular diseases in Pujiang community of Shanghai. Public Health and Preventive Medicine. 2012; 23: 108–109.
[23] National Health and Family Planning Commission. China Health and Family Planning Statistical Yearbook 2017. Beijing: Publishing House of Chinese Union Medical University. 2017.
[24] Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet. 2013; 381: 1987–2015.
[1] Peter A. McCullough, Raphael B. Stricker, Harvey A. Risch. Role of hydroxychloroquine in multidrug treatment of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 545-546.
[2] Guinan Xie, An Yan, Peng Lin, Yi Wang, Liping Guo. Trimethylamine N-oxide—a marker for atherosclerotic vascular disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 787-797.
[3] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[4] Wanting Wang, Zhaoqiang Feng, Jinghui Bai. Effects of alirocumab on cardiovascular events and all-cause mortality: a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 873-881.
[5] Yaowang Lin, Feng Liu, Shuying Gong, Bihong Liao, Huadong Liu, Jie Yuan, Danqing Yu, Haiyan Qin, Meishan Wu, Shaohong Dong. Validity of SOFA score as a prognostic tool for critically ill elderly patients with acute infective endocarditis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 967-973.
[6] Rosa Agra-Bermejo, Alberto Cordero, Pedro Rigueiro Veloso, Diego Iglesias Álvarez, Belen Álvarez Álvarez, Brais Díaz, Leyre Alvarez Rodríguez, Charigan Abou-Jokh, Belén Cid Álvarez, Jose R. González-Juanatey, Jose M García Acuña. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 475-482.
[7] Peter A. McCullough, Paul E. Alexander, Robin Armstrong, Cristian Arvinte, Alan F. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew C. Berry, Thomas J. Borody, Joseph H. Brewer, Adam M. Brufsky, Teryn Clarke, Roland Derwand, Alieta Eck, John Eck, Richard A. Eisner, George C. Fareed, Angelina Farella, Silvia N. S. Fonseca, Charles E. Geyer Jr., Russell S. Gonnering, Karladine E. Graves, Kenneth B. V. Gross, Sabine Hazan, Kristin S. Held, H. Thomas Hight, Stella Immanuel, Michael M. Jacobs, Joseph A. Ladapo, Lionel H. Lee, John Littell, Ivette Lozano, Harpal S. Mangat, Ben Marble, John E. McKinnon, Lee D. Merritt, Jane M. Orient, Ramin Oskoui, Donald C. Pompan, Brian C. Procter, Chad Prodromos, Juliana Cepelowicz Rajter, Jean-Jacques Rajter, C. Venkata S. Ram, Salete S. Rios , Harvey A. Risch, Michael J. A. Robb, Molly Rutherford, Martin Scholz, Marilyn M. Singleton, James A. Tumlin, Brian M. Tyson, Richard G. Urso, Kelly Victory, Elizabeth Lee Vliet, Craig M. Wax, Alexandre G. Wolkoff, Vicki Wooll, Vladimir Zelenko. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 517-530.
[8] Brian C. Procter, Casey Ross, Vanessa Pickard, Erica Smith, Cortney Hanson, Peter A. McCullough. Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 611-614.
[9] Yin-jun Mao, Hang Wang, Jian-xing Chen, Pin-fang Huang. Meta-analysis of medical management versus catheter ablation for atrial fibrillation[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 419-432.
[10] Peter A. McCullough, John Eidt, Janani Rangaswami, Edgar Lerma, James Tumlin, Kevin Wheelan, Nevin Katz, Norman E. Lepor, Kris Vijay, Sandeep Soman, Bhupinder Singh, Sean P. McCullough, Haley B. McCullough, Alberto Palazzuoli, Gaetano M. Ruocco, Claudio Ronco. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 1-7.
[11] Akanksha Agrawal, Hafeez Ul Hassan Virk, Iqra Riaz, Deepanshu Jain, Byomesh Tripathi, Chayakrit Krittanawong, Benham Bozorgnia, Vincent Figueredo, Peter A. McCullough, Janani Rangaswami. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 123-127.
[12] Wan Chin Hsieh, Anas Aboud, Brandon M. chael Henry, Mohamed Omara, Jaroslav Lindner, Jan Pirk. Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 161-169.
[13] Yun Tian, Pingji Deng, Bing Li, Jieqiong Wang, Ju Li, Yulan Huang, Yan Zheng. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance[J]. Reviews in Cardiovascular Medicine, 2019, 20(1): 27-33.
[14] Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[15] Nasrien E. Ibrahim, Akshay S. Desai, Jagmeet P. Singh, James L. Januzzi Jr. Advances in Heart Failure Management: Improving Outcomes With Innovation[J]. Reviews in Cardiovascular Medicine, 2017, 18(S1): 1-16.
No Suggested Reading articles found!